Is BHC stock a Buy, Sell, or Hold?

Based on our analysis, BHC is currently a HOLD with moderate confidence. 📊 HOLD: BHC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

What is the fair value of BHC stock?

Our analysis estimates the fair value range for BHC to be between $5.68 and $6.06. The current price is $5.89.

What is the analyst price target for BHC?

The average Wall Street analyst price target for BHC is $7.50. This implies a potential upside of 27.3% from current levels.

Bausch Health Companies (BHC) Stock: Buy, Sell, or Hold?

BHC - Bausch Health Companies Inc

PHARMACEUTICAL PREPARATIONS

$5.89

0.00 (0.00%) ▲

5d: -4.23%

30d: +3.88%

90d: +19.47%

HOLD

MODERATE Confidence

Protect Your BHC Gains

Analysis Updated: Oct 14, 2026 12:00 AM ET

Earnings: Oct 28, 2026 12d

Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Oct 12, 2026 at $5.93 · last confirmed Oct 14, 2026

Strength: 6.7/10

Get Alerted When BHC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
📊 HOLD: BHC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: -5.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$5.85

Based on -0.5% avg growth

INTRINSIC VALUE TODAY

$3.63

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 1.4x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: BHC is currently trading at $5.89, which is considered fair relative to its 30-day fair value range of $5.68 to $6.06. The stock's valuation (Forward PE: 1.4) is in line with its historical norms (1.4). Remarkably, the market is currently pricing in an annual earnings decline of 0.9% over the next few years. This pessimistic expectation contrasts with the company's recent 70.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, BHC is in a strong uptrend. Immediate support is located at $5.61, while resistance sits at $6.34.

Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $7.50 (+27.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR

Historical Trading Range $5.68 - $6.06

Company Quality Score 54/100 (HOLD)

Volume Confirmation HIGH

Confidence Score 72.4%

Protect Your Profits

Holding BHC? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

NEUTRAL: Price in fair range
NEUTRAL: Mixed technical signals (44/100)
BULLISH: High volume confirmation
BULLISH: Trading 27.3% below Wall St target ($7.50)
NEUTRAL: Bottoming setup forming (44/100) — watch for confirmation

Trading Range Analysis

30-Day Trading Range $5.68 - $6.06

Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $5.61

Resistance Level $6.35

Current Trend Strong Uptrend

Technical data as of Oct 14, 2026

Fundamental Context

Forward P/E (Next Year Est.) 1.37

Wall Street Target $7.50 (+27.3%)

Revenue Growth (YoY) 12.7%

Earnings Growth (YoY) 70.4%

Profit Margin -10.1%

Valuation Discount vs History -0.9% cheaper

PE vs Historical 1.4 vs 1.4 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -0.9% (market-implied from PE analysis)

1-Year Target $5.84 (-1%)

2-Year Target $5.78 (-2%)

3-Year Target $5.73 (-3%)

3-Yr Target (if PE normalizes) (PE: 1→1) $5.85 (-1%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 19.9, Growth: -5.0%) $73.00 (+1139%)

Base: (SPY PE: 1.4, Growth: -5.0%) $5.04 (-14%)

Bear: (PE: 1.2, Growth: -5.0%) $4.29 (-27%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 1.4 to 1.4

Stabilization Target: $6.01 (+2.0%)

PE Expansion Potential: +2.0%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: October 14, 2026 7:22 PM ET
Data refreshes hourly during market hours. Next update: 8:22 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is BHC showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for BHC.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NBIX Neurocrine Biosciences I…	STRONG BUY 29 analysts	$207	53 HOLD
ALKS Alkermes Plc	STRONG BUY 19 analysts	$57	64 BUY
ELAN Elanco Animal Health	STRONG BUY 16 analysts	$31	54 HOLD
AMLX Amylyx Pharmaceuticals I…	STRONG BUY 12 analysts	$42	59 HOLD
AQST Aquestive Therapeutics I…	STRONG BUY 9 analysts	$9	57 HOLD

NBIX Neurocrine Biosci…

53 HOLD

ALKS Alkermes Plc

64 BUY

ELAN Elanco Animal Hea…

54 HOLD

AMLX Amylyx Pharmaceut…

59 HOLD

AQST Aquestive Therape…

57 HOLD

Advanced BHC Option Strategies

Professional options setups generated by AI based on today's BHC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BHC

BHC Technical Chart BHC Price Prediction BHC Earnings Date Why is BHC Moving Today? BHC Investment Advisor BHC Fair Price Analyzer BHC Options Advisor BHC Options Chain BHC Options Analysis BHC Competitors

Compare BHC with Peers

BHC vs ELAN
Which one to buy?

BHC vs BLCO
Which one to buy?

BHC vs BHVN
Which one to buy?

BHC vs CPRI
Which one to buy?

BHC vs GDRX
Which one to buy?

BHC vs STOK
Winner: BHC

BHC vs PRTA
Winner: PRTA

BHC vs KPTI
Winner: BHC

BHC vs BCRX

BHC vs NVCT
Winner: BHC

Create New Comparison View All Competitors

Tradestie